Jennifer E MersereauSummaryAffiliation: University of North Carolina Country: USA |
Detail Information
Publications
The role of alendronate in mitigating perimenopausal bone loss: a double-blind randomized controlled pilot studyJennifer E Mersereau
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California, USA
Fertil Steril 94:1138-40. 2010..Compared with placebo, alendronate treatment resulted in a significant protection against bone loss in healthy perimenopausal women. This protection occurred at both the spine and the hip and was evident after 6 months of therapy...
